Skip To Main Content
Shunkichi Ikegaki on Muck Rack

Shunkichi Ikegaki

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shunkichi

Contact Shunkichi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Hepatitis B Boosters Using a Different Product vs. the Same Product for Kidney Transplant Recipients: A Retrospective Study With Bayesian Inference

|
By Kentaro Iwata, Shunkichi Ikegaki, Hideaki Miyake, Yoji Hyodo
| Wiley Online Library Verified
1 Introduction Hepatitis B vaccination is recommended for those who receive kidney transplants because the recipients are at increased risk of infection [1, 2]. A series of three vaccinations provides protective antibody against hepatitis B surface antigen (HBsAg) in 93%–97% of healthy adults [3, 4], but the seroconversion rate drops sharply to 63%–65% among those with end-stage renal disease (ESRD), and 18%–36% among kidney transplant recipients (KTR) [3, 5, 6].
Open in Who Shared Issue with article?

Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center

|
By Yuki Kataoka, Takehiro Otoshi, Shunkichi Ikegaki, Emiko Saito
| PLOS
In this study, we aimed to examine the clinical value of the pleural effusion (PE) biomarkers, soluble mesothelin-related peptide (SMRP), cytokeratin 19 fragment (CYFRA 21–1) and carcinoembryonic antigen (CEA), and the utility of combining chest computed tomography (CT) findings with these biomarkers, in diagnosing malignant pleural mesothelioma (MPM). We conducted a retrospective cohort study in a single center.
Open in Who Shared Issue with article?
See all 2 articles